Sharekhan

Albert David Ltd

Fri 25/04/2025,15:19:59 | NSE : ALBERTDAVD

₹ 846.80-30.55 (-3.48%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 882.80

Previous Close

₹ 877.35

Volume

6872

Mkt Cap ( Rs. Cr)

₹483.28

High

₹ 882.80

Low

₹ 842.05

52 Week High

₹ 1753.95

52 Week Low

₹ 762.60

Book Value Per Share

₹ 724.06

Dividend Yield

1.30

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Albert David Ltd

Your Vote -

Buy

81.82%

Hold

9.09%

Sell

9.09%

81.82%

22 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Albert David Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Albert David Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    16 Apr 2025, 7:41PM As of March 2025, 62.23% is owned by Indian Promoters and 37.76% by Public. <p align=justify> Institutional holds 2.64% (Insurance Companies 1.61%) an
  • Albert David Ltd - Disclosure under SEBI Takeover Regulations

    16 Apr 2025, 5:40PM Arun Kumar Kothari has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31(5) of the Securities and Exchange Board of India (
  • Albert David Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    4 Apr 2025, 6:16PM Albert David Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Albert David Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    4 Apr 2025, 5:23PM Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the period 01-01-2025 to 31-03-2025
  • Albert David Ltd - Trading Window-XBRL

    21 Mar 2025, 7:16PM ALBERT DAVID LIMITED has informed the Exchange about Closure of Trading Window
  • Albert David Ltd - Trading Window

    21 Mar 2025, 7:15PM Albert David Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201
  • Albert David Ltd - Resignation of Independent director

    10 Mar 2025, 5:27PM ALBERT DAVID LIMITED has informed the Exchange about Resignation of Independent director.
  • Albert David Ltd - Resignation

    10 Mar 2025, 5:05PM Albert David Limited has informed the Exchange regarding Resignation of SHIRISH as Independent Director of the company w.e.f. March 10, 2025.
  • Albert David Ltd - Announcement under Regulation 30 (LODR)-Change in Directorate

    10 Mar 2025, 4:16PM Resignation of Mr. Shirish Gundopant Belapure, Independent Director w.e.f 10.03.2025.
  • Albert David Ltd - Copy of Newspaper Publication

    14 Feb 2025, 12:32PM Albert David Limited has informed the Exchange about Copy of Newspaper Publication
  • Albert David Ltd - Copy of Newspaper Publication

    13 Feb 2025, 6:23PM Albert David Limited has informed the Exchange about Copy of Newspaper Publication
  • Albert David Ltd - Financial Result Updates

    12 Feb 2025, 5:39PM Albert David Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Albert David Ltd - Integrated Filing- Financial

    12 Feb 2025, 5:33PM Integrated Filing (Financial) for the third quarter and nine months ended 31st December 2024
  • Albert David Ltd - Outcome of Board Meeting

    12 Feb 2025, 5:24PM Albert David Limited has informed the Exchange regarding Board meeting held on February 12, 2025.
  • Albert David Ltd posts Q3 net loss of Rs 9.39 cr

    12 Feb 2025, 5:20PM The company reported standalone net loss during the quarter stood at Rs 9.39 crore compared to net profit of Rs 18.72 crore in the previous year quart
  • Albert David Ltd - Unaudited Financial Results For Quarter And Nine Months Ended 31St December,2024

    12 Feb 2025, 5:01PM Unaudited Financial Results for quarter and Nine Months ended 31st December, 2024.
  • Albert David Ltd - Integrated Filing (Financial)

    12 Feb 2025, 4:55PM Integrated Filing (Financial) for quarter and Nine Months ended 31-12-2024.
  • Albert David Ltd - Board Meeting Outcome for Outcome Of Board Meeting Dated 12-02-2025

    12 Feb 2025, 4:29PM Outcome of Board Meeting dated 12-02-2025
  • Albert David Ltd - Board Meeting Intimation

    1 Feb 2025, 5:59PM ALBERT DAVID LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2025 to inter-alia consider and approve the Unaudited Financia
  • Albert David Ltd - Board Meeting Intimation for To Consider, Approve, And Take On Record The Un-Audited Financial Results Of

    1 Feb 2025, 5:43PM ALBERT DAVID LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and a

Key fundamentals

Evaluate the intrinsic value of Albert David Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 385.0809 315.5417 283.2368 244.8149 224.2421
Liabilities 385.0809 315.5417 283.2368 244.8149 224.2421
Equity 5.7072 5.7072 5.7072 5.7072 5.7072
Gross Profit 46.8796 44.3433 40.7942 19.1484 30.3143
Net Profit 75.4201 36.1749 35.2583 22.143 19.1686
Cash From Operating Activities 45.5022 10.515 40.3647 36.6107 30.0934
NPM(%) 20.8 10.59 11.24 8.94 5.97
Revenue 362.4617 341.5644 313.5114 247.4499 320.795
Expenses 315.5821 297.2211 272.7172 228.3015 290.4807
ROE(%) 18.25 8.75 8.53 5.35 4.63

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
02 Aug 2024 11.5 115 1.36 1201.95
03 Aug 2023 9 90 1.36 596.4
01 Aug 2022 9 90 1.36 545.85
06 Sep 2021 6 60 1.36 513.4
13 Mar 2020 7 70 1.36 411.35
01 Aug 2019 6 60 1.36 490.55
24 Aug 2018 5.5 55 1.36 388
01 Sep 2017 5.5 55 1.36 316.55

Peers

Other companies within the same industry or sector that are comparable to Albert David Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Lotus Eye Hospital and Institute Ltd 73.85 8.16 307.71 1829.87 14.01 0.68
Vaishali Pharma Ltd 13.77 -3.97 459.00 943.18 2.76 0.00
Astec Lifesciences Ltd 711.55 -3.71 0.00 1725.41 -687.11 0.00
Suraksha Diagnostic Ltd 313.35 0.58 52.40 60.71 226.82 0.00

Company Info

The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.

The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.

Read More

Parent Organisation

Albert David Ltd.

Founded

16/11/1938

Managing Director

Mr.Umesh Manohar Kunte

NSE Symbol

ALBERTDAVDEQ

FAQ

The current price of Albert David Ltd is ₹ 846.80.

The 52-week high for Albert David Ltd is ₹ 882.80 and the 52-week low is ₹ 842.05.

The market capitalization of Albert David Ltd is currently ₹ 483.28. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Albert David Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Albert David Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Albert David Ltd shares.

The CEO of Albert David Ltd is Mr.Umesh Manohar Kunte, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT